Partial and full agonists of A1 adenosine receptors
AssigneeCV Therapeutics, Inc.
InventorsJeff Zablocki, Venkata Palle, Elfatih Elzein, Xiaofen Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeCV Therapeutics, Inc.
InventorsJeff Zablocki, Venkata Palle, Elfatih Elzein, Xiaofen Li
Estimating the term…
Disclosed are A1 adenosine receptor agonists of the formula: wherein: R1 is optionally substituted cycloalkyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl; R2 is hydrogen, halo, trifluoromethyl, or cyano; R3 is hydrogen, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted heterocyclyl, R4 and R5 are independently hydrogen or optionally substituted acyl; X is a covalent bond or lower alkylene optionally substituted by cycloalkyl; X1 is a covalent bond or alkylene; Y is a covalent bond or lower alkylene optionally substituted by hedroxy or cycloalkyl; and Z is —C≡C—, —R6C═CR7—, or —CHR6CHR7—, in which R6 and R7 at each occurrence are hydrogen or lower alkyl.
A compound of the formula:
Dependencies are inferred from the claim text.